Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Jordan Healthcare Press.
Press releases published on August 14, 2025
Akari Therapeutics to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech
GlobeNewswire
·
August 14, 2025
BOSTON and LONDON, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), a biotechnology company developing novel Antibody Drug Conjugates (ADCs) with immuno-oncology payloads for the treatment of cancer, today announced that it will …
Senti Biosciences to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech
GlobeNewswire
·
August 14, 2025
SOUTH SAN FRANCISCO, Calif., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio”), a clinical-stage biotechnology company developing next-generation cell and gene therapies using its proprietary Gene Circuit platform, …
Moleculin to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech
GlobeNewswire
·
August 14, 2025
– Live video webcast on Wednesday, August 20th at 2:00 PM ET HOUSTON, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a late-stage pharmaceutical company with a broad portfolio of drug candidates …
GRI Bio to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech
GlobeNewswire
·
August 14, 2025
Live video webcast on Wednesday, August 20th at 2:20 PM ET LA JOLLA, CA, Aug. 14, 2025 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (“NKT”) cell …
Carlsmed Inc. to Report Second Quarter 2025 Financial Results on August 28, 2025
GlobeNewswire
·
August 14, 2025
CARLSBAD, Calif., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced it will report its second quarter 2025 financial results after …
Last patient visit completed on schedule in Phase 1b clinical trial of HER-096 for Parkinson’s disease
GlobeNewswire
·
August 14, 2025
Patient visits are now complete in the final cohort of Phase 1b trial, consisting of Parkinson’s disease patients receiving 300 mg doses of HER-096 or placebo twice weekly over a four-week period Primary objective is to assess the safety, tolerability and …
Trinity Biotech Receives Regulatory Approval to Begin FDA-Cleared PreClara™ Preeclampsia Testing Service
GlobeNewswire
·
August 14, 2025
DUBLIN, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced that this week its New …
Vaso Corporation Announces Financial Results for Second Quarter of 2025
GlobeNewswire
·
August 14, 2025
PLAINVIEW, N.Y., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Vaso Corporation (“Vaso”) (OTCQX: VASO), a leading MedTech company with a diversified business portfolio in network and healthcare IT services, professional sales services and proprietary medical products, …
Imprivata Patient Access Under Construction in Epic Toolbox for Identity Verification in MyChart
GlobeNewswire
·
August 14, 2025
WALTHAM, Mass., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Imprivata, a leading provider of access management solutions for healthcare and other mission-critical industries, today announced that Imprivata Patient Access is now under construction in Epic Toolbox in …
Scienture Holdings, Inc. Announces Pricing of $3.9 Million Registered Direct Offering of Common Stock
GlobeNewswire
·
August 14, 2025
Commack, NY, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Scienture Holdings, Inc. (Nasdaq: SCNX) (“Scienture” or the “Company”), a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced value to patients, physicians …
AIM ImmunoTech to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech
GlobeNewswire
·
August 14, 2025
OCALA, Fla., Aug. 14, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), today announced that it will present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech being held virtually August 19- …
Easy Environmental Solutions Secures Full Down Payment for First EasyFEN™ Units in Africa
GlobeNewswire
·
August 14, 2025
Full down payment on $3.4 million order confirms Kenyan launch Each EasyFEN™ unit designed to deliver $19 million in recurring revenue annually while restoring farmland at scale Production at full capacity in Mankato with public showcase scheduled before …
Clene Reports Second Quarter 2025 Financial Results and Recent Operating Highlights
GlobeNewswire
·
August 14, 2025
Following constructive FDA feedback on its proposed statistical analysis plan, Clene plans to analyze the neurofilament light data from its large NIH-sponsored Early Access Protocol early in the fourth quarter of 2025 A second Type C meeting has been …
scPharmaceuticals Receives Notice of Allowances of Multiple US Patent Applications Covering SCP-111
GlobeNewswire
·
August 14, 2025
BURLINGTON, Mass., Aug. 14, 2025 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH) (the “Company”), a pharmaceutical company committed to revolutionizing cardiorenal healthcare through patient-centric innovations, announced today that it has …
Salarius Pharmaceuticals Announces 1-for-15 Reverse Stock Split
GlobeNewswire
·
August 14, 2025
HOUSTON, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX), a clinical-stage biopharmaceutical company using protein inhibition and protein degradation to develop cancer therapies for patients in need of new treatment options, …
Global Botulinum Toxins Market to Surge to USD 15.7 Billion by 2030 | MarketsandMarkets™.
GlobeNewswire
·
August 14, 2025
Delray Beach, FL, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Rising demand for minimally invasive procedures, preventive aesthetics, and novel therapeutic uses position botulinum toxins as a high-growth segment in global healthcare. The global botulinum toxins …
Adial Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
·
August 14, 2025
GLEN ALLEN, Va., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related …
Autonomix Medical, Inc. Finalizes Design Review of First-Ever Intravascular Nerve Sensing Catheter in Key Step Toward U.S. Clinical Studies
GlobeNewswire
·
August 14, 2025
Microchip-based platform enables real-time nerve mapping and targeted treatment from within the vascular system Continued progress toward submitting Investigational Device Exemption (“IDE”), and if approved, the commencement of U.S. clinical trials to …
Tiziana Life Sciences Doses First Patient in Phase 2a Trial of Intranasal Foralumab for Multiple System Atrophy
GlobeNewswire
·
August 14, 2025
BOSTON, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a fully …
Enlivex to Present 3-Month Topline Data from Phase IIa Moderate/Severe Knee Osteoarthritis Trial on August 18 Webinar
GlobeNewswire
·
August 14, 2025
Webinar to Review Results from Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study Evaluating Allocetra™ in Patients with Moderate to Severe Knee Osteoarthritis Nes-Ziona, Israel, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. ( …